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Tumor invasion into surrounding stromal tissue is a hallmark
of high grade, metastatic cancers. Oncogenic transformation of
human epithelial cells in culture can be triggered by activation
of v-Src kinase, resulting in increased cellmotility, invasiveness,
and tumorigenicity and provides a valuable model for studying
how changes in gene expression cause cancer phenotypes. Here,
we show that epithelial cells transformed by activated Src show
increased levels of DNA methylation and that the methylation
inhibitor 5-azacytidine (5-AzaC) potently blocks the increased
cell motility and invasiveness induced by Src activation. A pro-
teomic screen for chromatin regulators acting downstream of
activated Src identified the replication-dependent histone
chaperone CAF1 as an important factor for Src-mediated
increased cell motility and invasion. We show that Src causes a
5-AzaC-sensitive decrease in both mRNA and protein levels of
the p150 (CHAF1A) and p60 (CHAF1B), subunits of CAF1.
Depletion of CAF1 in untransformed epithelial cells using
siRNA was sufficient to recapitulate the increased motility and
invasive phenotypes characteristic of transformed cells without
activation of Src.Maintaining high levels of CAF1 by exogenous
expression suppressed the increased cell motility and invasive-
ness phenotypes when Src was activated. These data identify a
critical role of CAF1 in the dysregulation of cell invasion and
motility phenotypes seen in transformed cells and also highlight
animportantrole forepigeneticremodelingthroughDNAmeth-
ylation for Src-mediated induction of cancer phenotypes.
The viral Src oncogene (v-Src) is the prototypic tyrosine
kinase and triggers cellular transformation and cancer malig-
nancy in chicken cells upon Rous sarcoma virus infection (1, 2).
Homologous Src family kinases encoded in the human genome
are proto-oncogenes and frequently overactivated in human
cancers, including breast cancer (3, 4), suggesting that high
endogenous Src activity is important in regulating molecular
mechanisms involved in carcinogenesis and/or cancer mainte-
nance (5, 6). In human cells, overexpression ofwild-type human
Src family kinases typically does not increase tumorigenicity. In
contrast, expression of the hyperactive v-Src kinase is sufficient
to drive oncogenic transformation (7, 8), consistent with the
idea that Src kinase activity, rather than simply Src kinase
abundance, is associated with tumorigenicity. v-Src-mediated
transformation produces hallmark characteristics of cancer,
including anchorage-independent growth, increased cell inva-
siveness, tumor-initiating capacity when injected into immu-
nocompromised nude mice (8–10), and metabolic reprogram-
ming (11). In vivo, these phenotypes are associated with
increased malignancy and metastatic potency, leading to
increased clinical severity (12).
The MCF10A Src-ER cell line provides a model system to
study the biochemical mechanisms of oncogenic transforma-
tion induced by Src activation. TheMCF10A cell line is a spon-
taneously immortalized, non-cancerous humanmammary epi-
thelial cell line derived from the breast tissue of a patient with
fibrocystic disease (13) that retains characteristics of primary
cultures of breast epithelium. The MCF10A Src-ER line is a
derivative that expresses an exogenous gene coding for Src-ER,
a fusion protein with the ligand binding domain from estrogen
receptor (ER)3 fused to the carboxyl terminus of v-Src (8). As
illustrated in Fig. 1A, treatment of MCF10A Src-ER cells with
4-hydroxytamoxifen (4-OHT) activates Src-ER kinase through
a conformational change followed by self-phosphorylation on
Tyr416 (corresponding to Tyr419 in human Src), triggering phe-
notypic transformation. MCF10A Src-ER cells transformed
with 4-OHT show phenotypes associated with metastatic
tumors that are absent before Src activation (8, 14). Src activa-
tion results in global changes in mRNA and microRNA levels
(8, 14), and activation of NF-B and IL-6 signaling are impor-
tant for cell transformation in this model (8, 15).
Here, we identify a novel role for the CAF1 complex inmedi-
ating specific phenotypes induced by v-Src activation that are
characteristic of invasive, transformed cells. The CAF1 com-
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plex is part of the machinery maintaining chromatin structure
in human cells (16). CAF1 is a histone chaperone that positions
histone H3 and H4 dimers into nucleosomes on newly synthe-
sized chromatin, especially during the S phase (17). It is a con-
served heterotrimeric complex, comprising three essential pro-
tein subunits, i.e. p150, p60, and p48 (18), with homologs in
yeast, insects, plants, and vertebrates (19, 20). Most recently, it
has been reported that CAF1 is also important for maintaining
differentiated cell states in mouse (21). This study showed that
the generation of induced pluripotent stem cells was facilitated
by depletion of CAF1.
Wehave compared chromatin-associated proteins inMCF10A
Src-ER cells under basal conditions and after Src-mediated
transformation. These data, togetherwith additional functional
analyses, reveal an unexpected dependence on DNA methyla-
tion and a critical role for human CAF1 in regulating specific
oncogenic phenotypes caused by v-Src activation, including
increased cell motility and invasiveness.
Results
v-Src-stimulated Cell Motility Is Dependent on DNA
Methylation—First, we confirmed that active Src is required
for increased motility and invasive phenotypes. Treatment of
MCF10A Src-ER cells with 4-OHT increases the active, Tyr416-
phosphorylated formof Src (Fig. 1B), disrupts the characteristic
epithelial “cobblestone” cell morphology (Fig. 1C, top panels),
increases actin filopodia (Fig. 1C, bottom panels), and increases
cell invasiveness (Fig. 1, D and E). Treatment with 4-OHT did
not cause similar phenotypic changes in the parental MCF10A
cell line, which lacks Src-ER (data not shown). Also, transfor-
mation phenotypes were not observed inMCF10A Src-ER cells
depleted of Src-ER with siRNA targeting ER before treatment
with 4-OHT (Fig. 1F). The rapid phenotypic transformation
observed is consistent with previous studies (8, 22). We con-
clude that phenotypic transformation of MCF10A Src-ER cells
is dependent upon increased activity of v-Src kinase rather than
indirect effects of 4-OHT treatment.
Src transformed epithelial cells proliferate slower than con-
trol cells (see below), albeit without changing the frequency of
cells in the respective G1, S, and G2/M cell cycle phases (Fig.
1G). Cellular senescence can result from oncogene activation
(23, 24). However, as judged using a -galactosidase assay, the
slowdown in proliferation of MCF10A cells following Src-me-
diated transformation was not accompanied by significant lev-
els of cellular senescence. In contrast, etoposide treatment
induced cellular senescence (Fig. 1H).
We next testedwhether Src-induced phenotypes are affected
by DNA methylation levels, which are important for gene
silencing. Our aim was to investigate the potential role of epi-
genetic mechanisms in affecting the expression of genes
required for the increased motility and invasiveness pheno-
types caused by Src activation. MCF10A Src-ER cells were
treated with a combination of vehicle, 4-OHT, and/or 5-AzaC,
an irreversible inhibitor of DNA methyltransferases (3). Fol-
lowing treatment, the cells were assayed for both DNAmethyl-
ation levels and cell invasiveness. The total levels of methylated
cytidine increase after Src activation, as measured by DNA dot
blot (Fig. 2A). The methylated cytidine signal was abolished
after pretreatment of cells with 0.3 M 5-AzaC for 24 h (Fig.
2A). Control, untransformed MCF10A cells treated with
5-AzaC alone exhibit little or no change in cell invasiveness
under normal growth conditions (Fig. 2C). In contrast, prein-
cubation with 5-AzaCmarkedly reduced levels of invasive cells
following Src activation (Fig. 2 B and C), compared with cells
preincubated with vehicle (DMSO) (Fig. 1, D and E), which
cannot be explained simply by lower proliferation rates
(Fig. 2D).
Remarkably, under these conditions cell invasiveness was
almost completely suppressed and fell below the levels seen in
control cells prior to Src activation. However, treatment of
MCF10A Src-ER cells with 5-AzaC did not prevent phosphor-
ylation of Src at Tyr416 (Fig. 2E). The 5-AzaC treatment also did
not prevent the profound changes in cell morphology, includ-
ing the characteristic disruption of the cobblestone epithelial
pattern, seen after Src activation and cell transformation (Fig.
2F). We infer that Src activation modulates distinct down-
stream pathways that differentially control phenotypes associ-
ated with cell transformation and that DNAmethylation influ-
ences mechanisms regulating the increase in cell motility and
invasiveness in transformed cells.
Src-dependent Changes in the Chromatin Proteome—We
hypothesized that the increase in motility and invasiveness in
transformed cells may result from Src-induced repression of
DNAmethylation-dependent genes that suppress motility and
invasion. To test this hypothesis, we examined changes in chro-
matin-associated proteins resulting from Src activation by a
quantitative proteomics analysis (illustrated in Fig. 3A).
MCF10A Src-ER cells were grown in culture media contain-
ing either the normal (12C and 14N) isotopomers of arginine and
lysine (“light” or R0K0), or else in medium with arginine and
lysine substituted with heavy isotopes (“heavy” or R10K8).
Heavy labeled cells were treated with 4-OHT for 48 h, whereas
light labeled cells were treated with vehicle (ethanol) alone for
48 h, then 2 108 cells from each population were mixed, and
a chromatin-enriched fraction was isolated from the mixed
heavy and light-labeled cells. Chromatin enrichment was con-
firmed by immunoblotting for histone H3 (Fig. 3A, bottom
panel). This SILAC analysis was carried out in biological tripli-
cate and proteins in the chromatin fractions processed for LC-
MS/MS analysis (see “Experimental Procedures” and Fig. 3). In
total, 28,197 peptides were identified, and 2,020 proteins, each
with two or more peptides, were quantitated from the isolated
chromatin fractions. All of these raw MS data are accessible at
ProteomeXchange (accession PXD005494). The processed and
quantified data are also freely available in a user-friendly format
in the Encyclopedia of Proteome Dynamics (5), an open access,
searchable online database of large scale proteomic data sets.
This analysis identified specific proteins whose abundance
was altered 48 h after Src activation, although the expression
levels of most of the chromatin proteins detected showed little
or no change (Fig. 3B). Within the transformation responsive
proteins, we focused on those with GO annotations linked with
nuclear localization and/or function (Fig. 3B) and excluded
from further analysis proteins reported to artifactually co-frac-
tionate with chromatin (25), such as cytoskeletal proteins. Pro-
teinswere deemed significantly changed if the following criteria
Cell Motility Effectors in Src-transformed Epithelial Cells
JANUARY 6, 2017•VOLUME 292•NUMBER 1 JOURNAL OF BIOLOGICAL CHEMISTRY 173
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on January 13, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
were met: log2 SILAC ratio of less than1 or log2 SILAC ratio
of greater than 1, with a p value of less than 0.05. Proteins that
meet the stringent cutoff and filtering criteria are shown in
Table 1. After 48 h of Src activation, the levels of proteins p150,
HLTF, UHRF1, MAFF, and CEBPD all decreased in the chro-
matin fraction, whereas JUNB increased (Fig. 3B and Table 1).
qRT-PCR analyses of p150, HLTF, UHRF1, andMAFFmRNAs
show parallel mRNA changes, indicating that the decreases in
protein levels are likely transcriptionally regulated (Fig. 3C).
p150 Depletion Stimulates Cell Motility—Next, we tested for
causal links between protein abundance changes and the Src-
induced transformed phenotypes by performing a focused phe-
notypic RNAi screen for genes where single siRNA depletion of
expression leads to a phenotype. Independent depletion of
either p150, HLTF, UHRF1, or MAFF in untransformed
MCF10A Src-ER cells showed that depletion of either HLTF,
UHRF1, orMAFF caused little or no change in cell morphology
(data not shown). Note that these data do not exclude the pos-
FIGURE 1.MCF10A Src-ER, an oncogenic transformationmodel. A, schematic illustration of theMCF10A Src-ERmodel system for Src-mediated cellular transfor-
mation. B, total cell lysates fromMCF10A Src-ER cells treated for 48 hwith either EtOHor 1M4-OHT,were immunoblottedwith antibodies against pSrc (Tyr416) and
-tubulin.C, representative lightmicroscopy imagesofMCF10ASrc-ERcells treatedfor48hwitheitherEtOHor1M4-OHT.Scalebar, 50m.Lightmicroscopy images
show representative fields of cells fromeach condition (top panels).MCF10ASrc-ER cells treated for 48hwith either EtOHor 1M4-OHTwere stainedwithphalloidin
and DAPI (bottom panels). Scale bar, 10 m. D, Transwell invasion assay. Cells treated for 48 h with either EtOH or 1 M 4-OHT were seeded into a Matrigel-coated
Transwell invasion chamber and incubatedovernightwith chemoattractant in thebottomchamber. Invading cellswere counted from10 independent fields at 20
magnification.Scalebar,50m.E, the individualvalues(graycircle),means(blackbox),andS.D.ofmeansof invadingcells fromafieldareshown.ThemeansS.D.were
derived from three biological replicates. F, representative lightmicroscopy images ofMCF10A Src-ER cells transfected for 72 hwith siRNA against ER and treated for
48 hwith either EtOH, or 1M 4-OHT. Scale bar, 50m.G, MCF10A Src-ER cells treated for 48 hwith either EtOHor 1M 4-OHTwere stainedwith PI and analyzed by
flow cytometry. The individual values (gray circle), means (black box), and S.D. ofmeans of cell frequencies from cell cycle phases are shown. Themeans S.D. were
derived fromfivebiological replicates.H, representative lightmicroscopy imagesofMCF10ASrc-ERcells treated for48hwitheitherEtOHor1M4-OHTor for1hwith
20M etoposide and stained using a senescence-galactosidase staining kit. Scale bar, 50m.
Cell Motility Effectors in Src-transformed Epithelial Cells
174 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 292•NUMBER 1•JANUARY 6, 2017
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on January 13, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
sibility that HLTF, UHRF1, orMAFF gene functions contribute
to affecting cell morphology but rather indicate that individual
depletion did not induce a strong morphology phenotype.
Interestingly, depletion of p150 alone did result in disruption of
the typical regular epithelial morphology, resembling the mor-
phological heterogeneity induced by Src activation (Figs. 1C
and 4A). A similar morphological change was observed follow-
ing siRNA knockdown of p150 with four separate siRNAs and
using all four together in a pool (Fig. 4A), consistent with the
phenotype resulting from depletion of p150 and suggesting it is
unlikely to be an off target effect. Thesemorphological changes
following p150 depletion occurredwithout any change in either
the abundance or the phosphorylation level of Src (Fig. 4B).
The proteomic data showing decreased p150 protein levels
after Src activation were confirmed by immunoblot analysis
(Fig. 4C). A corresponding decrease was detected in p150
mRNA, indicating thatmodulation of p150 protein levels by Src
likely involves a transcriptional mechanism (Fig. 3C). p150/
CHAF1A is a subunit of CAF1, an essential complex that
recruits histones to nascent chromatin during the S phase (16).
We next tested whether the CAF1 subunit p60/CHAF1B was
similarly regulated by Src (Fig. 4, C and D). Levels of both p60
FIGURE 2. Inhibiting DNAmethylation prevents cell invasiveness. A, cells were treated with the indicated combinations of EtOH, 1 M 4-OHT, and 0.3 M
5-AzaC. Thequantified signals from theDNAdotblot using ananti-methylcytidine antibody shows the totalDNAmethylation levels of genomicDNAextracted
from each condition. The individual values (gray circle), means (black box), and S.D. of means of 5-methylcytidine signals are shown. The means S.D. were
derived from four biological replicates. B, Transwell invasion assay. The cells were treated with the indicated combinations of EtOH, 1 M 4-OHT, and 0.3 M
5-AzaC; seeded intoaMatrigel-coatedTranswell invasionchamber; and incubatedovernightwith chemoattractant in thebottomchamber. Invadingcellswere
counted from10 independent fields at 20magnification. Scale bar, 50m.C, the individual values (gray circle),mean (blackbox), andS.D. ofmeansof invading
cells from a field are shown. The means  S.D. were derived from three biological replicates. D, MCF10A Src-ER cells treated with a combination of vehicle
controls, 1M 4-OHT, and 0.3M 5-AzaCwere counted 96 h after plating. The individual values (gray circle), means (black box), and S.D. ofmeans of cell counts
are shown. Themeans S.D. were derived from six biological replicates. E, total cell lysates fromMCF10A Src-ER cells treatedwith a combination of EtOH and
1M4-OHTwith 0.3M5-AzaCwere immunoblottedwith the antibody against pSrc (Tyr416). F, representative lightmicroscopy images ofMCF10A Src-ER cells
treated with a combination of EtOH and 1 M 4-OHT with 0.3 M 5-AzaC. Scale bar, 50 m.
Cell Motility Effectors in Src-transformed Epithelial Cells
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protein (Fig. 4C) and mRNA (Fig. 4D) decreased after Src-me-
diated transformation, similar to p150. Furthermore, the p150
and p60 CAF1 subunits remain associated in both control and
Src-transformed cells, as judged by their co-immunoprecipita-
tion (Fig. 4E). Thus, we conclude that Src-mediated transfor-
mation down-regulatesCAF1 subunits, thereby reducingCAF1
levels and likely impairing CAF1 function.
To evaluate the role of CAF1 function in the inducible Src
system, we first confirmed that depletion of p150 with siRNA
co-depletes the p60 CAF1 subunit (Fig. 4B), as previously
FIGURE 3. Quantitative proteomic screen for chromatin-associated regulators of cell motility and invasiveness. A, cells grown in either light (R0K0) or
heavy (R10K8) SILACmediumwere treated for 48 h with either EtOH or 1 M 4-OHT, respectively. Equal numbers of MCF10A Src-ER cells from each condition
were mixed, and the subcellular fractions were isolated. Total cell lysates (TCL) and cytoplasm (Cy), nucleoplasm (Nu), and chromatin (Ch) fractions were
immunoblotted with antibodies against the marker proteins, -tubulin (Cy), lamin B1 (Np), and histone H3 (Ch) (bottom panels). Proteins in the chromatin
fractions were in-gel digested with trypsin, and tryptic peptides were analyzed by LC-MS/MS. B, the mean log2 SILAC ratio (transformed/untransformed) and
log10p valueof potential chromatin-associatedproteins are indicated in the x and y axes, respectively. Themeanvalues andp valueswerederived from three
biological replicates. The scatter plot was visualized using Datashop. Chromatin-associated proteins significantly changed upon 4-OHT treatment are high-
lighted. C, total RNA from MCF10A Src-ER cells treated for 48 h with either EtOH or 1 M 4-OHT were analyzed by qRT-PCR. Expression levels of p150, HLTF,
UHRF1, andMAFFwere normalized byGAPDHpre-mRNA level, and expression levels in cells treatedwith EtOHwere set to 1. The individual values (gray circle),
means (black box), and S.D. of means of relative mRNA levels are shown. The means S.D. were derived from three biological replicates.
Cell Motility Effectors in Src-transformed Epithelial Cells
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reported (7). Thus, siRNAdepletion of p150modulates levels of
theCAF1 complex, allowing characterization of the phenotypic
consequences of reduced CAF1 in untransformed MCF10A
Src-ER cells. In the absence of Src induction, CAF1 depletion
increases the frequency of MCF10A Src-ER cells in the S phase
by10%, compared withmock-depleted control cells (Fig. 4F),
consistent with the histone recruitment function of CAF1 dur-
ing replication (9, 10). We also analyzed by immunofluores-
cence microscopy whether the organization of the actin cyto-
skeleton was affected by depleting CAF1 (Fig. 4G). In cells
transfected with control siRNA, actin was predominantly in
typical stress fibers. In CAF1-depleted cells, this pattern was
disrupted and podia-like actin structures, which are often
observed inmotile cells, were detected (arrows in Fig. 4G), sim-
ilar to what is observed following Src activation (Fig. 1C).
We next performed both wound healing and Transwell
Matrigel invasion assays to assess the effect of CAF1 depletion.
The wound healing assay compared the changes in the mea-
sured area of a wound, from the time of wounding to a fixed
time after wounding, setting initial wound sizes to 100%. For
control cells transfected with non-targeted siRNA, the wound
size at 16 h after wounding was only reduced to 87.0  4.9%
(Fig. 5, A and B). In contrast, for CAF1-depleted cells, at 16 h
after wounding, the wound size was reduced to 45.0  7.3%.
This indicates an increased sealing speed of cells at the wound
area after CAF1 depletion (Fig. 5, A and B).
CAF1 depletion also increased invasiveness in untrans-
formed cells without Src activation. The number of invading
cells increased 5-fold after CAF1 depletion, compared with
control cells transfectedwith non-targeted siRNA (Fig. 5,C and
D). This is similar to transformed cells 48 h after Src activation
(Fig. 1, D and E). We conclude that CAF1 levels are likely
important for suppressing cell motility and invasiveness in
untransformed MCF10A cells.
These changes in cell morphology and motility mirror phe-
notypic changes reported for the epithelial to mesenchymal
transition (EMT), which was shown to play a role in cancer
development (26). Therefore, we next examined the expression
levels of EMT marker proteins, including E-cadherin, -
catenin, claudin, Snail, and Slug, following CAF1 depletion in
untransformed cells (Fig. 5, E and F). This showed that the
expression levels of some of these markers change in a fashion
consistent with typical EMT, suggesting that CAF1 depletion
leads to an EMT-like phenotype driven by Slug, claudin and
potentially -catenin (see “Discussion”).
High p150 Levels Suppress Motility in Src-transformed
Cells—To investigate the potential role for CAF1 in mecha-
nisms regulating motility and invasiveness, we exogenously
expressed p150  Src activation and tested how this affected
cellular phenotypes. To do this, MCF10A Src-ER cells were
transduced with lentiviruses coding for either GFP alone or
GFP-p150 and analyzed by fluorescence microscopy (Fig. 6).
Free GFP was diffusely spread throughout the cells, with a
strong cytoplasmic signal, whereas GFP-p150 showed nuclear
localization and was expressed at similar levels to endogenous
p150 (Fig. 6, A and B).
Lentivirus transduced cells expressing either GFP or GFP-
p150 were treated for 48 h with either EtOH alone (control) or
with 4-OHT (Fig. 6C) and assayed for cell invasiveness (Fig.
6D). Src activation in cells expressing GFP alone resulted in the
expected increase in cell invasiveness, as compared with cells
with basal Src activity (Fig. 6D). However, the cell invasiveness
of Src-transformed cells expressing exogenous GFP-p150 was
reduced by 50% compared with Src-transformed cells
expressing GFP alone, whereas there was little or no difference
in the low levels of cell invasion activity betweenuntransformed
MCF10A Src-ER cells expressing either GFP alone, or GFP-
p150 (Fig. 6D). The fact that the Src-induced increase in cell
invasiveness can be suppressed, at least in part, by preventing
p150 protein levels decreasing strongly supports a role for
CAF1 inmechanisms affecting cellmotility in cells transformed
by Src activation.
To investigate whether p150 levels also affected cell motility
in other transformed cell types, we transduced U2OS cells,
derived fromhuman osteosarcoma,with lentiviruses coding for
either GFP alone or GFP-p150 and assayed for cell migration
(Fig. 6E). Migration by U2OS cells expressing exogenous GFP-
p150was reduced by50% comparedwithU2OS cells express-
ing GFP alone (Fig. 6E). This is consistent with a broader role of
p150 in the regulation of cell motility.
Regulation of p150 Levels—Next, we investigated the mecha-
nism that couples Src activation with the down-regulation of
CAF1 subunit mRNA and protein levels. Our experiments
above show that the CAF1 subunit genes, p150 and p60, are
TABLE 1
Chromatin proteins regulated by Src
Protein IDs
Gene
names Descriptions
Log2 SILAC
ratio p value
Proteins down-regulated
upon 4-OHT treatment
Q14527 HLTF Helicase-like transcription factor 1.149 0.007
Q13111 CHAF1A Chromatin assembly factor 1 subunit p150 1.147 0.049
Q96T88 UHRF1 E3 ubiquitin-protein ligase UHRF1 1.111 0.010
P78549 NTHL1 Endonuclease III-like protein 1 1.060 0.029
P98179 RBM3 Putative RNA-binding protein 3 1.052 0.034
Q9ULX9 MAFF Transcription factor MafF 1.042 0.022
P49716 CEBPD CCAAT/enhancer-binding protein delta 1.039 0.006
Q14676 MDC1 Mediator of DNA damage checkpoint protein 1.005 0.005
Proteins up-regulated upon
4-OHT treatment
P14618 PKM2 Pyruvate kinase isozymes M1/M2 1.376 0.023
P78371 CCT2 T-complex protein 1 subunit  1.186 0.031
P17275 JUNB Transcription factor jun-B 1.113 0.006
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both transcriptionally regulated by v-Src (Figs. 3C and 4D). Our
hypothesis is that the increase we observed in DNA methyla-
tion upon Src activation may lead, either directly, or indirectly,
to transcriptional repression of p150 and p60 gene expression.
To test this, we preincubated MCF10A Src-ER cells with
5-AzaC, then treated cells with 4-OHT to induce Src activity
and measured expression of the p150 and p60 genes. Interest-
ingly, both the mRNA and protein levels of p150 and p60
remain similar to control, untransformed cells (Fig. 7,A and B).
We conclude that 5-AzaC treatment prevents the Src-mediated
decrease in p150 and p60 gene and protein expression and
hence maintains CAF1 levels. This rescue of CAF1 expression
by 5-AzaC treatment parallels the suppression of the Src-in-
duced increase in cell motility and invasiveness by 5-AzaC
shown previously (Fig. 2). Our data thus show that Src activa-
tion regulates expression of CAF1 subunits through a mecha-
nism that is sensitive to 5-AzaC treatment, likely via modula-
tion of DNA methylation levels.
Discussion
In this study we show that DNAmethylation levels in human
epithelial cells increase following Src-mediated oncogenic
transformation andmay affect genes regulating cancer cell phe-
notypes. This indicates a role for epigenetic gene silencing
mechanisms in control of the increased cell motility and inva-
siveness resulting fromSrc activation.Using anunbiased, quan-
titative proteomics screen, we identified the chromatin assem-
bly factor, CAF1, as having a key role inmechanisms promoting
Src-induced transformed cell phenotypes, including increased
invasiveness and motility. Reduction in the expression levels of
CAF1 subunits appears necessary for promoting increased cell
motility and invasiveness following oncogenic transformation.
FIGURE 4. CAF1 is a regulator of cell morphology andmotility. A, transmission lightmicrographs of cells treatedwith control siRNA, each of four individual
siRNAs targeting p150, and the combined pool of the four siRNAs targeting p150. B, total cell lysates fromMCF10A Src-ER cells treated with control siRNA and
p150 siRNAwere immunoblotted with antibodies against p150, p60, pSrc (Tyr416), and -tubulin. C, total cell lysates fromMCF10A Src-ER cells treated for 48 h
with either EtOHor 1M 4-OHTwere immunoblottedwith antibodies against p150, p60,-tubulin, andGAPDH.D, total RNA fromMCF10A Src-ER cells treated
for 48 hwith either EtOHor 1M4-OHTwere analyzed by qRT-PCR. Expression levels of p60were normalized byGAPDHpre-mRNA level, and expression levels
in cells treatedwith EtOHwere set to 1. The individual values (gray circle),means (black box), and S.D. ofmeans of relativemRNA levels are shown. Themeans
S.D.were derived from three biological replicates. E, Western blotting analysis of the CAF1 subunits p150 andp60 in p150 immunoprecipitates (IP) from lysates
prepared from MCF10A Src-ER cells treated for 48 h with either EtOH or 1 M 4-OHT. Inputs and immunoprecipitates were immunoblotted with antibodies
against p150 andp60. F, MCF10ASrc-ER cells transfected for 72 hwith either control siRNAor siRNA targeted top150were stainedwith PI and analyzedby flow
cytometry. The individual values (gray circle), means (black box), and S.D. ofmeans of cell frequencies from cell cycle phases are shown. Themeans S.D. were
derived from three biological replicates. G, MCF10A Src-ER cells transfected for 72 h with either control siRNA or siRNA against p150 were stained with
phalloidin and an antibody against p150, together with DAPI. Scale bar, 10 m.
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Exogenous expression of GFP-p150 from a lentiviral vector was
sufficient to strongly reduce the ability of activated Src to pro-
mote increased cell motility and invasiveness. Interestingly, it
also appears sufficient (at least in part), because targeted siRNA
depletion of CAF1 subunits in untransformed cells caused sim-
ilar increases in motility and invasiveness to that seen after Src
activation.
In addition to the major effect of decreased CAF1 levels on
stimulating cell motility and invasiveness, impairing CAF1
function also promoted other phenotypes seen in transformed
cells after Src activation. This included changes in cell shape
and morphology. The morphology of CAF1-depleted cells
became elongated and fibroblast-like, consistent with either a
Slug-driven (27) or a claudin-driven (28) EMT-like phenotype.
Previous reports have shown that up-regulation of either Slug
or claudin individually is sufficient to drive EMT. That we
observe both Slug and claudin increasing after CAF1 depletion
in untransformed cells suggests that Slug and/or claudin may
promote an EMT-like transition in these cells. Fig. 7C illus-
trates amodel linking these data on Src activation, CAF1 levels,
FIGURE 5. CAF1 is a regulator of cellmotility and invasiveness.A and B, MCF10A Src-ER cells transfected for 72 hwith either control siRNA or siRNA against p150
were wounded. Representative light microscopy images of wound areas are shown at 0 and 16 h after wounding. Scale bar, 100 m. The wound areas from five
independent fieldswereautomaticallymeasuredusingTScratchsoftware. Thecalculatedwoundsizesofeach fieldat0hwereset to100%.The individual values (gray
circle),means (blackbox), andS.D.ofmeansof relativewoundareasareshown.ThemeansS.D.werederivedfromthreebiological replicates.CandD, equalnumbers
of MCF10A Src-ER cells treated for 48 h with either EtOH or 1 M 4-OHT or transfected for 72 h with either control siRNA or siRNA against p150 were spread onto
Matrigel-coated invasion chambers. Representative light microscopy images show positively invading cells. Invading cells were counted as above. The individual
values (graycircle),means (blackbox), andS.D.ofmeansof invadingcells fromafieldareshown.ThemeansS.D.werederived fromthreebiological replicates.E, total
cell lysates fromMCF10A Src-ER cells treatedwith control siRNA andp150 siRNAwere immunoblottedwith antibodies against E-cadherin,-catenin, claudin, snail1,
snail2, vimentin,-tubulin, andGAPDH.F, dotblot showing thequantificationof the immunoblot signals inEand replicateanalyses. The individual values (gray circle),
means (black box), and S.D. ofmeans (error bars) of immunoblot signals were derived from three biological replicates.
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and transformation phenotypes in epithelial cells. Our working
hypothesis is that CAF1 regulates the expression of down-
stream target genes involved in the control of cell motility and
migration, potentially including interactions with the extracel-
lular matrix. An interesting goal for future experiments will be
to address themechanismof howSrc activation regulatesCAF1
protein levels.
Recent work in mice has shown that the generation of
induced pluripotent stem cells, essentially a dedifferentiation
process, was accelerated when CAF1 subunits were depleted
(21). It was proposed that CAF1 regulates the transition state
barrier between undifferentiated and differentiated cell states
and can play a critical role, therefore, in maintaining specific
differentiated cell types. For example, it was reported that
depletion of CAF1 subunits in mouse enhanced, inter alia, the
conversion of differentiated fibroblasts into neurons, with con-
comitant alterations to the previous fibroblast cell phenotypes
(21). Our present findings, in a human disease model, are con-
sistent with this proposed new role for the highly conserved
CAF1 complex in maintaining terminally differentiated cell
FIGURE 6. Exogenousp150expressionsuppresses cell invasiveness in transformedMCF10ASrc-ERcells.A,MCF10ASrc-ER cells transducedwitheitherGFPor
GFP-p150 were fixed and stainedwith DAPI. Scale bar, 10m. B, total cell lysates fromMCF10A Src-ER cells transducedwith either GFP or GFP-p150 were immuno-
blottedwith antibodies against GFP, p150, and-tubulin. C, total cell lysates fromMCF10A Src-ER cells transducedwith either GFP or GFP-p150 and treated for 48 h
with either EtOH or 1M 4-OHTwere immunoblottedwith antibodies against GFP, p150, pSrc (Tyr416), and-tubulin.D, MCF10A Src-ER cells transducedwith either
GFPorGFP-p150were treated for48hwitheitherEtOHor1M4-OHT.EqualnumbersofcellswerespreadontoMatrigel-coatedmembrane filters. Invadingcellswere
counted. The individual values (gray circle), means (black box), and S.D. ofmeans of invading cells from a field are shown. Themeans S.D. were derived from three
biological replicates. E, equal numbers of U2OS cells transducedwith either GFP or GFP-p150were spread ontomembrane filters. Migrating cells were counted. The
individual values (gray circle), means (black box), and S.D. of means of migrating cells from a field are shown. The means S.D. were derived from two biological
replicates.
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states. We show here that depletion of CAF1 levels in a human
breast epithelial cell line changes the phenotypes normally
associated with the terminally differentiated epithelial cell
state, promoting a fibroblast-like cell morphology.
Our present data using the MCF10A cell model include sev-
eral observations of potential clinical significance. First, the
human homolog of the v-Src oncogene, Src, is of clinical rele-
vance and Src activity and/or protein abundance is often highly
elevated in breast cancer (29). The Src locus is mutated and/or
amplified in some cancers, particularly intestinal cancers (40).
Despite these associations with cancer malignancy, the efficacy
of Src inhibitors in the clinic has been disappointing thus far.
However, this could potentially be improved through better
understanding of Src-dependent pathways that could be used
for patient stratification. The DNA methylation inhibitor
5-AzaC, which we find to strongly inhibit the ability of Src acti-
vation to promote cell invasion and motility phenotypes, has
been approved for clinical use and shown to have benefit as an
anti-cancer drug for treatment of certain classes of leukemias
(30, 31). Based upon our present findings, it could be important
to test whether 5-AzaC might also show clinical benefit in
reducing levels ofmetastases, associated either with breast can-
cer or other tumors, perhaps preferentially for patients previ-
ously showing elevated levels of Src activity or with altered
expression of factors acting downstream of activated Src.
CAF1 has been shown to be a clinical marker for cell prolif-
eration and associated with tumor aggressiveness and clinical
outcome. However, the nature of the association depends on
cancer type. For example, high levels of CAF1 marks prolifera-
tive cell populations in breast tissue (32), whereas reduced lev-
els of p150 protein have been frequently observed in oral squa-
mous cell carcinomas (33). Decreased p150 mRNA expression,
which we found here to be a downstream effect of inducing Src
activity in cell culture, was also detected in a study comparing
gene expression profiles of stromal cells in normal versus breast
cancer tissue, with both p150 and p60 mRNA levels signifi-
cantly decreased in all grades of tumors tested (34). The con-
trasting associations between CAF1 and clinical outcome sug-
gest that the role of CAF1 in tumorigenesis is complex andmay
be context-dependent, as suggested for other clinical markers
FIGURE 7.Src-mediated regulationof CAF1 subunits isDNAmethylation-dependent.A, total RNA fromMCF10ASrc-ER cells treatedwith a combination of
vehicles, 1 M 4-OHT, and 0.3 M 5-AzaC were analyzed by qRT-PCR. Expression levels of p150 and p60 were normalized by GAPDH pre-mRNA level and
expression levels in cells treatedwith vehicles were set to 1. The individual values (gray circle), means (black box), and S.D. ofmeans of relativemRNA levels are
shown. Themeans S.D. were derived from three biological replicates. B, total cell lysates fromMCF10A Src-ER cells treatedwith a combination of vehicles, 1
M 4-OHT, and 0.3 M 5-AzaC were immunoblotted with antibodies against p150, p60, and -tubulin. C, an illustrative model of how Src activation leads to
increased invasiveness andmotility through regulating CAF1 levels, consistent with the data presented in this study. This shows Src activation (green upward
arrow) promotingdecreasedCAF1 levels (red downward arrow), resulting in an increase inmotility, scattering, and invasionphenotypes (green upward arrows).
Themodel envisages a role for CAF1 in untransformed cells in suppressingmotility and invasiveness. Pretreatmentwith 5-AzaCdoes not prevent Src activation
but strongly suppresses the downstream activation of motility and invasion phenotypes normally caused by Src.
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(35); for example, depending onwhether the cellular etiology of
clinical severity is characterized by hyperplasia (proliferation)
and/or dysplasia (differentiation).We note, however, that these
data strongly support our findings here and other data indicat-
ing that human CAF1 functions as a regulator of global gene
expression.
Our data indicating an important role for the human CAF1
complex in cellmotility and invasion phenotypes, togetherwith
the recent report that CAF1 is critical for maintaining differen-
tiated cell states inmouse (21), suggest that oncogenic transfor-
mation by Src and potentially also cell transformation by other
oncogenes may be linked with creation of a meta-stable cell
state and transdifferentiation. It will be interesting to address
this possible link between stability of differentiated cell state
and cancer progression in future studies. For example, a
detailed characterization of the proteomic and gene expression
landscapes of the normal, stably differentiated epithelial cell
state and how this is changed in cell states associated with can-
cer may prove informative.
Experimental Procedures
Cell Culture—MCF10ASrc-ER cells were grown as described
previously (8). 293T andU2OScellswere grown inDMEM(Life
Technologies), supplementedwith 10% fetal bovine serum (Life
Technologies), 100 units/ml penicillin, 100 g/ml streptomy-
cin, and 2 mM L-glutamine (Life Technologies) at 37 °C in 5%
CO2. For SILAC labeling,MCF10A Src-ER cells were grown for
7 days in arginine- and lysine-free F-12/DMEM (Thermo
Fisher) supplemented with stable isotope-labeled arginine (R0
or R10) and lysine (K0 or K8) (CKGAS), dialyzed horse serum
(Dundee Cell Products), and the same supplements as normal
cell culture. The cells were treated with a final concentration of
1 M tamoxifen (4-OHT; Sigma), for 48 h and 0.3 M 5-AzaC
(Sigma), 24 h prior to 4-OHT treatment.
Immunoblotting, DNADot Blot, and Immunoprecipitation—
Immunoblotting was performed as described previously (5).
Genomic DNAwas extracted from cells using DNeasy kit (Qia-
gen) according to the manufacturer’s protocol. Primary anti-
bodies used for immunoblotting and DNA dot blot were anti-
phospho-Src (Y419, Cell Signaling Technology), anti--tubulin
(Sigma), anti-lamin B1 (Abcam), anti-histone H3 (Cell Signal-
ing Technology), anti-p150 (Cell Signaling Technology), anti-
p60 (Bethyl Laboratory), anti-GAPDH (Abcam), anti-E-
cadherin (Cell Signaling Technology), anti--catenin (Cell
Signaling Technology), anti-claudin (Cell Signaling Technol-
ogy), anti-snail1 (Cell Signaling Technology), anti-snail2 (Cell
Signaling Technology), anti-vimentin (Cell Signaling Technol-
ogy), anti-GFP (Roche), and anti-methylcytidine (Abcam) anti-
bodies. Immunoprecipitations were performed as previously
described (36). In brief, whole cellular extracts were prepared in
co-immunoprecipitation buffer (PBS containing 0.5% Triton
X-100, 1 mM EDTA, 100 mM sodium orthovanadate, 0.25 mM
PMSF, complete protease inhibitor (Roche)). After centrifuga-
tion, samples were quantified using the BCA method. The
supernatants (1 mg protein) were incubated for 2 h at 4 °C
with 3 g of anti-p150 antibody cross-linked to protein A/G-
Dynabeads, following the manufacturer’s instructions. The
immunocomplexes were extensively washed with co-immu-
noprecipitation buffer, and the immunoprecipitates were sub-
sequently elutedwith 0.1M citrate, pH2.5, and boiled at 95 °C in
Laemmli buffer. Precipitates and 5% of thewhole lysate amount
(input) were then used forWestern blotting analysis. As a con-
trol, lysates were incubated with irrelevant cross-linked rabbit
IgG.
Immunocytochemistry—Thecellswere fixedwith4%parafor-
maldehyde in PBS at room temperature for 10 min, permeabi-
lized with 0.2% Triton X-100 in PBS at room temperature for 5
min and incubated with 5% FBS and 0.1% Tween in PBS on ice
for 1 h. After blocking, the cells were incubated with primary
antibody at room temperature for 1 h. The cells were then
stained with Alexa Fluor 488-conjugated anti-rabbit IgG anti-
body (Life Technologies) and/or TRITC-conjugated phalloidin
(Cell Signaling Technology) at room temperature for 1 h and
with DAPI (Sigma) at room temperature for 10 min. Images
were capturedwith aDeltaVisionCore Restorationmicroscope
(Applied Precision).
Cell Invasion andMigration Assay—48 h after either 4-OHT
treatment or 72 h after siRNA treatment, assays were per-
formed as previously described (8).
Cell Cycle Analysis—Cellular DNA content profiles were
analyzed as previously described (37).
-Galactosidase Staining—Cellular senescence was evalu-
ated by -galactosidase staining using the senescence -galac-
tosidase staining kit (Cell Signaling Technology) according to
the manufacturer’s protocol. The cells were treated with a final
concentration of 20 M etoposide for 1 h.
Subcellular Fractionation—Approximately 2  108 cells
were detached with Accutase (Life Technologies), washed with
PBS once and resuspended in 5ml of buffer A (20mMTris-HCl,
pH 7.4, 10 mM KCl, 3 mMMgCl2, 0.1% Nonidet P-40, 10% glyc-
erol), followed by incubation on ice for 10 min. For SILAC
experiments, equal numbers of cells from R0K0 and R10K8
media were mixed prior to resuspension in buffer A. The cells
were mechanically homogenized using a needle and centri-
fuged at 1,000  g at 4 °C for 5 min. The pellets were resus-
pended in 3 ml of S1 solution (0.25 M sucrose, 10 mM MgCl2),
layered on 3 ml of S2 solution (0.35 M sucrose, 0.5 mM MgCl2),
and centrifuged at 1,430 g at 4 °C for 5 min. The pellets were
resuspended in 3 ml of S2 solution and sonicated to disrupt
nuclear membranes. Lysates were layered on S3 solution (0.88
M sucrose, 0.5 mM MgCl2) and centrifuged at 3,000 g at 4 °C
for 10 min. Supernatants were mixed with NPRB (20 mM
HEPES, pH 7.4, 7.5 mM MgCl2, 30 mM NaCl, 1% Nonidet P-40,
1 M urea at final concentration) and centrifuged at 13,000 g at
4 °C for 5 min. The pellets were resuspended in ChRB (50 mM
Tris-HCl, pH 8.0, 10 mM EDTA, 1% SDS) and completely son-
icated. Lysates were boiled at 95 °C for 20 min. After centrifu-
gation at 13,000  g at room temperature for 5 min, superna-
tants were collected and used as chromatin fractions.
In-gel Trypsin Digestion and Peptide Desalting—Proteins
from chromatin fractions were subjected to in-gel trypsin
digestion as previously described (5).
LC-MS/MS and Analysis and Data Processing—For tryptic
digests, including tryptic  Lys-C double digests, peptide
chromatography was performed using a Dionex RSLCnano
HPLC, as described previously (38). The data were pro-
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cessed, searched, and quantified using theMaxQuant software
package version 1.2.0.18 (39), using the default settings and
employing the humanUniProt database (June 7, 2011) contain-
ing 109,824 entries. Default mass tolerances were used and
maximum false positive rates of 1% were allowed for both pep-
tide and protein identification. Protein quantitation data were
derived from a minimum of two peptides/protein. MS data
were normalized and visualized using Perseus and Datashop.
qRT-PCR Analysis—Total RNA was extracted with RNeasy
kit (Qiagen). Quantification of mRNA was performed with
Light cycler 450 (Roche), using QuantiFast SYBR Green RT-
PCR kit (Qiagen) following the manufacturer’s protocol.
siRNATransfection—The cells were transfectedwith siRNAs
using Lipofectamine RNAiMax (Life Technology) at 20 nM final
siRNA concentration, according to the manufacturer’s proto-
col. The cells were harvested and analyzed 72 h after siRNA
transfection. The control siRNA sequence is 5-CAGU-
CGCGUUUGCGACUGG-3 (MWG). siRNAs utilized pools of
four different sequences (Thermo Fisher): LU-003402 (ER),
LU-019938 (p150), LU-019937 (p60).
Imaging of Cell Morphology and Wound Healing Assay—
Lightmicroscopy images of cells were recorded either 48 h after
4-OHT treatment or 72 h after siRNA transfection. The wound
healing assays were performed as previously described (14).
Images of cell wounds were taken at 0 and 16 h after wounding.
Opened wound sizes were measured by using TScratch
software.
ExpressionConstructs and Lentivirus Transduction—Human
cDNAs for p150 were obtained from Thermo Fisher. The
coding sequence for p150 was amplified by PCR from a cDNA
template and cloned into pEGFP-C1 (Clontech). To generate
pLVX-GFP and pLVX-GFP-p150, the corresponding se-
quences were amplified by PCR from constructs described
above and cloned into pLVX-puro vector (Clontech). For
lentivirus production, we triple-transfected 293T cells with
two plasmids encoding essential genes for lentivirus (gifts
from Ron Hay lab, University of Dundee) and either pLVX-
GFP, or pLVX-GFP-p150, by the calcium phosphate trans-
fection method. 16 h after transfection, the medium was
replenished. 72 h after transfection, supernatants containing
lentiviruses were filtered and concentrated. Lentiviruses
were used to transduce cells in the presence of 8 g/ml Poly-
brene (Millipore).
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